Invasive non-typhoidal Salmonella are a common cause of invasive disease in immuno-compromised individuals and in children. Multi-drug resistance poses challenges to disease control, with a critical need for effective vaccines. Flagellin is an attractive vaccine candidate due to surface exposure and high epitope copy number, but its potential as a target for opsonophacytic antibodies is unclear.
Introduction
Non-typhoidal Salmonella (NTS) disease is a major public health burden. It usually manifest as self-limiting gastroenteritis in humans [1] . However, in immuno-compromised individuals (such as malaria and HIV-infected patients) and children especially in developing countries, it predominantly manifests in an invasive NTS (iNTS) disease with bacteremia [2] [3] [4] , which is most commonly caused by Salmonella enterica serovars Typhimurium and Enteritidis. The case fatality of iNTS is 20-25% in children [3] and up to 47% in HIVinfected adults [5] . Increased drug resistance and emergence of new multi-drug resistant S. enterica strains has made iNTS disease difficult to manage [6] [7] [8] . There is very broad consensus that vaccines against iNTS are urgently needed. Several classes of vaccines against iNTS (e.g. live attenuated, polysaccharide, conjugates) are currently being considered, but no vaccine is currently licensed for use in humans [9] .
Antibodies and phagocytes are essential effectors that mediate protection against invasive salmonellosis [10] [11] [12] [13] [14] [15] . Salmonella growth in the tissues is paralleled by the spread of the microorganisms throughout the body via the extracellular space and by blood from established infection foci to new sites [16] . Cytokine-driven host responses recruit phagocytes to multicellular pathological lesions, trapping the bacteria within discrete foci of infection [12] [13] [14] 17] , where the antimicrobial action of reactive oxygen and nitrogen species (ROS and RNS) restricts intracellular growth [17] [18] [19] [20] . During their extracellular dispersion, Salmonella become vulnerable to antibodies and complement that opsonise the bacteria and target them to receptors on the surface of phagocytes, increasing the ROS-dependent antimicrobial functions of the host cells [12] [13] [14] [15] 17, [21] [22] [23] .
Infection with S. enterica induces production of antibodies against various bacterial targets such as flagellar proteins, outer membrane proteins, lipopolysaccharide (LPS), heat shock proteins and fimbriae [24] [25] [26] [27] [28] . However, the full spectrum of the antigen specificity of the protective antibody response against invasive salmonelloses is still unclear. The surface exposed FliC flagellin protein is involved in bacterial invasion as illustrated by reduced invasiveness of FliC-deficient mutants in vitro [29] , and contributes to bacterial virulence and protection in murine models of the disease [30] [31] [32] [33] . Therefore, flagellin may be an attractive vaccine candidate. Flagellin could also serve as a carrier and an adjuvant. The flagellum is a polymer of flagellin and hence acts as a multivalent antigen expressing multiple copies of the epitope. Flagella have been used as a carrier for foreign antigens and have shown efficient antibody induction to both the flagellin and foreign epitopes [34] [35] [36] . Being surface exposed, both the flagellin and the foreign epitopes are efficiently presented to the immune system. The flagellin protein interacts with Toll-like receptor 5 (TLR-5), which activates NFκB [37] . This leads to the induction of a pro-inflammatory immune response, giving the flagella its adjuvanticity.
Given the increasing interest in the use of flagella as an antigen target and as a carrier [34] [35] [36] 38] , we aimed to examine the potential efficacy of targeting the FliC protein with antibodies to enhance phagocyte functions known to be essential for protective immunity against Salmonella. We have previously shown that targeting the surface-abundant OmpA protein with human IgGs can increase the uptake and killing of bacteria by human phagocytic cells, the efficiency of these functions depending both on the subclass of the IgG and the FcR that is available for antibody binding [39] . Broadening the repertoire of antigens to be included in future iNTS multicomponent vaccines is desirable. Therefore, in the current study we used a similarly robust experimental system, where we tagged flagella with the CD52 mimotope (TSSPSAD) and then opsonised the bacteria with a panel of humanised CD52 antibodies that share the same antigenbinding V-region, but have constant regions of different subclasses.
Using this system, we investigated whether targeting flagella with antibodies can mediate key phagocyte functions associated with host resistance to infection, in particular phagocytosis and intracellular bacterial killing.
Materials and Methods

Reagents and media
All reagents and media were obtained from Sigma-Aldrich, Poole, UK unless stated otherwise.
Bacterial strains
S. Typhimurium LDV321 [40] is a non-motile derivative of parent strain SL3261 [41] , where fliC, fljA and fljB (but not the hin promoter) are excised. We generated a green fluorescent protein (GFP)expressing derivative of SL3261 by inserting a DNA fragment that consists of the gfp gene from Aequoria Victoria and a chloramphenicol resistance cassette between pseudogenes malX and malY on the chromosome by oligonucleotide-directed mutagenesis [42] . The DNA fragment consisting of the gfp gene and the chloramphenicol resistance cassette with 5' and 3' arms homologous to the DNA flanking the pseudogenes was amplified by PCR using primer pair MalXT (5'-CCG CAG GTT CAG TCG GTA AAA GAT GAA ATG GTT GGC CTG ATG AAT ACC GTT CAG GCA TAA CCT GGG GTA ATG ACT CTC TAG C-3') and MalYCam (5'-CTA CGT ACA CCA TGT CCC GCG TCG GTC AAC TTC CTG TGA AAA ATC GAA CAT ATC CCT TCC GAC GTC ATT TCT GCC ATT CAT CC-3'). Underlined regions of the primers indicate sequences complementary to the downstream region of the malX gene and sequences complementary to the upstream region of the malY gene respectively. To allow tagging of the flagella, we transformed GFPexpressing S. Typhimurium LDV321 with a recombinant pFF408 [40, 43] . The recombinant pFF408 was generated by inserting DNA encoding a short peptide (TSSPSAD), which is a mimotope of the human CD52 antigen, between unique XhoI and BglII restriction enzyme sites at the central region of the fliC gene in the plasmid pFF408 [43] . The fliC gene is under the native fliC promoter. To generate the fragment consisting of the sequence encoding for the TSSPSAD mimotope, we amplified a fragment upstream of the insertion site in pFF408 using primer pair CDPCRF3 (5'-CAT GAT TAC GAA TTC GTT ATC GGC-3') and CDPCRR3 (5'-TTT TTT CTC GAG ATC CGC GGA CGG GGA GGA GGT AGA TCT AGT ACC ACC AAG ACC AGT AGC-3'). Underlined segment of the CDPCRR3 primer encodes for the TSSPSAD mimotope, thereby inserting the mimotope to the fragment. This fragment that consisted of mimotope-encoding sequence was then inserted into pFF408 by conventional ligation. The insertion of the gfp gene between malX and malY genes and the insertion of the TSSPSAD mimotope-coding sequence in the fliC gene were confirmed by standard sequencing.
Expression of GFP and the mimotope were verified by immunofluorescence (see Supplementary Figure 1 ). We confirmed that the insertion of the CD52 mimotope did not interfere with assembly of the FliC flagella on the bacterial surface and the recombinant bacterial strain was motile (see Supplementary Figure 2 ). 
Cell culture
The human monocyte cell line THP-1 was grown in RPMI-1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine, 0.05 mM 2-mercaptoethanol at 37ºC. Prior to bacterial infection, THP-1 cells were grown in RPMI-1640 supplemented with 10% Nu serum (VWR), 
Bacterial opsonisation
Bacteria were opsonised as previously described [39] . Briefly, bacteria from an overnight culture were opsonised by incubation in either the humanised anti-TSSPSAD antibodies or the non-specific control antibody at a final concentration of 25 µg/ml (the highest concentration that does not agglutinate the bacteria) at 37°C with shaking for 30 min. The humanised anti-TSSPSAD antibodies share the same variable regions (CAMPATH-1 [45] ) that recognize the human CD52 mimotope, but are of different human antibody subclasses (either IgG1, IgG2, IgG3, or IgG4 [46, 47] ). The non-specific control antibody used in this study is the recombinant human Fog-1 IgG1 [47] antibody that recognizes the human RhD antigen. Unbound antibody was removed by extensive washing. Effective opsonisation was visualized by fluorescence microscopy using Alexa Fluor 568 conjugated goat anti-human IgG (Invitrogen).
Immunofluorescence
Following opsonisation at 37°C with shaking for 30 min with either the humanised anti-TSSPSAD antibodies or the non-specific control antibody at a final concentration of 25 µg/ml, unbound antibody was removed by washing. The opsonized bacteria were then labeling with Alexa 568 conjugated goat anti-human IgG and visualized by fluorescence microscopy.
Infection of THP-1 cells with S. Typhimurium
Following opsonisation, the bacteria were added to the THP-1 cells at multiplicity of infection (MOI) of 10:1 (bacteria: THP-1 cells) and incubated for 45 min at 37 ºC [39] . The infected cells were then washed five times with PBS. Any remaining extracellular bacteria were killed by incubating the infected cells with fresh culture medium containing 100 μg/ml gentamicin for 1 h. This time point was taken as 0 h. For time point 8 h, the medium was replaced with fresh medium supplemented with 10 μg/ml gentamicin and the cells were incubated at 37 ºC for another 8 h.
Determination of the number of visible intracellular viable bacteria
Twelve hours prior to infection, THP-1 cells were seeded onto poly-L-Lysine treated coverslips (Fisher Scientific). THP-1 cells were infected with opsonised bacteria. At 0 h, THP-1 cells were fixed with 4% paraformaldehyde for 15 min before staining with mouse monoclonal anti-O4 antibodies (Abcam) and subsequently with secondary goat anti-mouse Alexa Fluor 405 antibody (Invitrogen). All antibodies were diluted 1:1000 in 10% normal goat serum (Dako). Coverslips were mounted onto Vecta bond-treated glass slides (Vector Laboratories) with mounting medium (Vectashield, Vector Laboratories) and viewed using a Leica DM6000B fluorescence microscope. Intracellular bacteria were discriminated from extracellular bacteria by the presence of GFP and the absence of labeling by the mouse monoclonal anti-O4 antibodies. For experiments exploring the percentage of infected cells and intracellular bacterial load distributions, 450 infected host cells were counted for each one of three repeats.
Determination of intracellular bacterial viable counts
At each time point, the infected THP-1 cells were harvested by lysing with 0.1% Triton-X for 15 min. Viable bacterial colony-forming units (CFU) in the lysates were determined by the pour plate technique using LB agar.
Host cell cytotoxicity
Host cell death was determined using the Cytotox 96 nonradioactive cytotoxicity assay (Promega) according to manufacturer's protocol. The assay quantifies the amount of the cytosolic enzyme, lactate dehydrogenase (LDH), released into the supernatant when the membrane integrity of the cells was compromised as a result of cell death.
Statistical analysis
All sets of experiments were performed as three independent biological replicates (n=3). For determination of intracellular viable bacterial counts and cell cytotoxicity, each independent set of experiment was carried out in technical duplicate. Comparisons between means were conducted using the paired Student's t-test. We considered every possible paired combination between groups and controlled for the familywise error rate using a Holm-Bonferroni correction. P value of <0.05 is considered to be significant. The data described in this study are all statistically significant.
Results
Targeting flagella with antibodies can enhance phagocytosis of S.
Typhimurium by human cells
To examine whether antibodies that bind flagella can modulate bacterial uptake by human phagocytic cells, we used an approach that involves opsonisation of bacteria with recombinant humanised IgGs followed by the addition of the opsonised bacteria to the human phagocyte THP-1 cell line in vitro. We generated a recombinant S. Typhimurium LDV321-GFP strain where we inserted the CD52 mimotope TSSPSAD into FliC, allowing targeting by a panel of humanised anti-TSSPSAD antibodies with identical antigen-binding V-regions and different IgG constant regions (IgG1, IgG2, IgG3 and IgG4). Following a 45 min exposure to the opsonised bacteria, THP-1 cells were incubated for 1 h with culture medium containing 100 μg/ml of gentamicin to kill any extracellular bacteria. This is indicated as time point 0 h. We used the percentage of infected cells and the numbers of intracellular bacteria per infected cell as robust parameters to determine the effect of anti-flagella antibodies on bacterial uptake.
Opsonisation with specific antibodies that target S. Typhimurium flagella resulted in a higher percentage of infected cells ( Figure 1A) , as compared to the non-specific control human IgG1 antibody. Comparing among the different antibodies, the percentages of infected cells were statistically different between all the IgG subclasses; the highest percentage was observed when the bacteria were opsonised with IgG3, followed by IgG1, IgG4 and IgG2. We then studied the effects of opsonisation on the intracellular bacterial loads. We determined the number of visible intracellular bacteria per infected cell by immunofluorescence. Extracellular bacteria were identified by immunolabelling with mouse monoclonal anti-O4 antibodies, while intracellular bacteria were identified by the presence of GFP and the absence of the mouse monoclonal anti-O: 4 antibody labeling. When the bacteria were opsonised with anti-TSSPSAD antibodies, we Citation: Goh YS, Armour KL, Clark MR, Grant AJ, Mastroeni P (2016) Igg Subclasses Targeting the Flagella of Salmonella Enterica Serovar observed bacterial loads per phagocyte skewed towards higher intracellular densities ( Figure 1B) , as compared to the non-specific control antibody. Comparing among the different antibodies, the percentage of infected cells containing more than three bacteria was the highest when we used anti-TSSPSAD IgG3 antibodies to opsonize the bacteria (50%), followed by IgG1 (38%), IgG4 (32%) and IgG2 (22%). We considered every possible paired combination between the different antibody groups and controlled for the familywise error rate using a Holm-Bonferroni correction. The differences for all combination pairs of antibody (either with control isotype or with other isotype) were statistically significant.
Antibody binding to flagella can enhance the reduction in intracellular numbers of S. Typhimurium within human phagocytes
We have shown that antibodies targeting the flagella of S. Typhimurium via the TSSPSAD mimotope can enhance the uptake of S. Typhimurium by phagocytes. Next, we examined the effect of flagella-targeting antibodies on the numbers of viable intracellular bacteria. To explore this, we compared the intracellular viable bacterial counts from infected THP-1 cell lysates at 0 h and at 8 h post infection (p.i.). This was determined by counting the numbers of viable intracellular bacteria in the infected THP-1 lysates at both time points by plating on agar.
Opsonisation with all subclasses of anti-TSSPSAD antibodies resulted in higher numbers of viable intracellular bacteria at 0 h p.i., as compared with the non-specific control antibody (Figure 2A) . Comparing among the different antibodies, opsonisation with IgG3 resulted in the highest number of intracellular bacteria, followed by IgG1, IgG4 and IgG2 with statistically significant differences between all subclasses. At 8 h p.i., we observed lower intracellular viable bacterial counts for the bacteria opsonised with any of the antibodies, as compared with the counts at 0 h p.i. (Figure 2B ). At 8 h p.i., the intracellular viable bacterial counts were the lowest in the cultures infected with bacteria opsonised with anti-TSSPSAD IgG3, followed by IgG1, IgG4, IgG2 and lastly, non-specific control antibody. We confirmed that the lower viable bacterial counts observed at 8 h p.i. were not due to a higher level of death of the infected THP-1 cells, which would result in exposure of the bacteria to the extracellular antibiotic ( Figure S3 ). After 8 h of infection, opsonisation with IgG3 resulted in the lowest percentage of host cell death, followed by IgG1, then by IgG4 and non-specific control antibody, and lastly by IgG2. It is possible that, due to the higher efficiency in bacterial killing with IgG3 opsonisation, there is lower host cell death. At 0 h p.i., no significant levels of host cell death were observed.
We also calculated the magnitude of the reduction in intracellular bacterial numbers as the difference in the intracellular viable counts at 0 h and 8 h p.i. Opsonisation with specific antibodies targeting the flagella resulted in a greater reduction in the intracellular viable bacterial counts ( Figure 2C) , as compared to the non-specific control antibodies. When the bacteria were opsonised by anti-TSSPSAD antibodies, we observed a greater reduction in the intracellular viable bacterial counts with IgG3, followed by IgG1, IgG4 and IgG2. purified in a conformation that retains immunogenicity. However these criteria do not guarantee that targeting a surface protein results in efficient enhancement of phagocyte functions, one of the main correlated of protection in invasive Salmonella infections. Therefore functional data on the effect of antibody binding to candidate surface antigens are essential for preclinical vaccine development. The Salmonella flagellum is a main bacterial target, inducing efficient antibody production upon infection [25] [26] [27] . Due to its surface localization, repetitive epitopes along their structure, and TLR-5associated pro-inflammatory adjuvanticity, flagella can be considered as good protein carriers for inclusion in conjugate vaccines against iNTS. However, to date, it is has not been clear whether antibodies against flagella can enhance opsonophagocytosis and killing of the bacteria by human phagocytes.
The key findings of this study are that: i) targeting flagella with antibodies enhances phagocytosis and subsequent reductions in intracellular loads of viable bacteria; and ii) different isotypes of human IgG differ in their ability to modulate phagocytosis and reductions in intracellular bacterial numbers. Opsonisation resulted in an increase in bacterial uptake, as observed with a higher percentage of infected cells, higher bacterial numbers per cell, and a higher number of viable intracellular bacterial counts at 0 h p.i. (as compared to the non-specific control isotype). Following the initial phagocytosis event, specific antibody opsonisation also resulted in a greater reduction in the number of viable intracellular bacterial counts at 8 h p.i. (as compared to the non-specific control isotype). The magnitude of this reduction in the observed 8 h time frame is indicative of bacterial killing by the host cells, although differences in the bacteriostatic functions of phagocytes may also play a minor role in the observed phenomena.
We found that the efficiency in mediating bacterial uptake and reductions in intracellular bacterial numbers by IgG targeting the flagella differs, depending on the IgG subclasses. IgG3 is more efficient than IgG1, followed by IgG4 and then IgG2. For all studied parameters of bacterial uptake (namely the percentage of infected cells, the intracellular bacterial distribution and the viable intracellular bacterial counts at 0 h p.i.), the increase of bacteria uptake was the greatest when S. Typhimurium was opsonised with IgG3, followed by IgG1, IgG4 and lastly, IgG2. We have observed the similar pattern between the IgG subclasses in intracellular bacterial killing at 8 h p.i.. One possible reason for the difference in the anti-bacterial killing ability between the different isotypes is the difference in the molecular flexibility of the different subclasses. The greater flexibility of the hinge region of IgG3 probably allows IgG3 to associate better with activating Fcγ receptors such as FcγRI and FcγRIIA [46, 48, 49] to mediate efficient bacterial uptake and the subsequent intracellular bacterial killing, possibly hence resulting in lower host cell death at 8 h p.i.. In fact, Th1associated IgG3 has been shown to be more advantageous than the other subclasses in other infection systems, where IgG3 is negatively associated with progression of clinical diseases [50] . We have recently demonstrated that Th1-associated murine IgG2a and IgG2b were the most efficient isotypes at lowering Salmonella bacterial load in the blood, liver and spleen in vivo following infection in mouse [51] . Taken together, this has implications in the formulation of the vaccine and the design of the vaccination regimes as the data suggest that formulations and regimes that induce a Th1 response that is predominantly IgG3 antibody response could offer better protection against NTS.
In conclusion, our findings serve as a proof-of-principle, demonstrating that antibodies targeting flagella can enhance bacterial phagocytosis and intracellular bacterial killing against S. Typhimurium efficiently. Efficient uptake of the bacteria by phagocytic cells is particularly important as this could lead to efficient clearance of the bacteria from the bloodstream, and hence possibly reducing the occurrence of NTS bacteremia. In addition, the efficient intracellular bacterial killing by phagocytic cells is critical to containment of the infection which could lead to a faster resolution of the disease. Other studies have also illustrated a role for flagella in T-cell immunity and its association with protection in mice [31, 34, 52, 53] .
Our study therefore support the notion that flagella-based vaccines, either as purified subunit protein preparations or as flagellapolysaccharide conjugates have the potential to be promising vaccine candidates for protection against NTS.
We have previously shown that antibodies targeting OmpA [39] and lipopolysaccharides (LPS) [51] can increase bacterial uptake and eventual bacterial killing. It is therefore interesting to speculate that combination vaccines eliciting the right IgG isotype profile against ompA, flagella and LPS antigens, possibly also though carefully chosen delivery systems, may have the potential of being highly protective against iNTS infections.
